Furthermore, our findings, in conjunction with genetic associations with RA and CHD, and now T1D at the same locus, suggest IL-6 signaling pathways as a potential mechanistic link between these conditions, with immediate clinical relevance given the increased risk of CHD in RA [41], [42] and T1D patients [43], [44]. The gene discussed is IL6; the disease is rheumatoid arthritis.